terazosin

Generic: terazosin

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name terazosin
Generic Name terazosin
Labeler chartwell rx, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

terazosin hydrochloride 5 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-460
Product ID 62135-460_45adc1ec-ddd8-7c36-e063-6294a90a46a8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075614
Listing Expiration 2026-12-31
Marketing Start 2021-04-30

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135460
Hyphenated Format 62135-460

Supplemental Identifiers

RxCUI
260376 313215 313217 313219
UPC
0362135460907 0362135459901 0362135458904 0362135461904
UNII
D32S14F082

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name terazosin (source: ndc)
Generic Name terazosin (source: ndc)
Application Number ANDA075614 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 90 CAPSULE in 1 BOTTLE (62135-460-90)
source: ndc

Packages (1)

62135-460-90 90 CAPSULE in 1 BOTTLE (62135-460-90)

Ingredients (1)

terazosin hydrochloride (5 mg/1)

Linked Drug Pages (1)

Terazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "45adc1ec-ddd8-7c36-e063-6294a90a46a8", "openfda": {"upc": ["0362135460907", "0362135459901", "0362135458904", "0362135461904"], "unii": ["D32S14F082"], "rxcui": ["260376", "313215", "313217", "313219"], "spl_set_id": ["da4ca0f8-6888-447e-9948-d37196c5a19a"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (62135-460-90)", "package_ndc": "62135-460-90", "marketing_start_date": "20230201"}], "brand_name": "Terazosin", "product_id": "62135-460_45adc1ec-ddd8-7c36-e063-6294a90a46a8", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "62135-460", "generic_name": "Terazosin", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA075614", "marketing_category": "ANDA", "marketing_start_date": "20210430", "listing_expiration_date": "20261231"}